196 related articles for article (PubMed ID: 16414250)
1. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
De Deyn PP; Buitelaar J
Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
[TBL] [Abstract][Full Text] [Related]
2. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
3. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
Kurz A; Schwalen S S; Schmitt A
Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
5. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
7. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.
Buitelaar JK; van der Gaag RJ; Cohen-Kettenis P; Melman CT
J Clin Psychiatry; 2001 Apr; 62(4):239-48. PubMed ID: 11379837
[TBL] [Abstract][Full Text] [Related]
10. Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study.
Biederman J; Mick E; Faraone SV; Wozniak J; Spencer T; Pandina G
Clin Ther; 2006 May; 28(5):794-800. PubMed ID: 16861101
[TBL] [Abstract][Full Text] [Related]
11. Duration of risperidone treatment for BPSD.
Snowdon J; Brodaty H; Ames D; Day S
Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
[No Abstract] [Full Text] [Related]
12. Risperidone for Psychosis-Induced Aggression or Agitation.
Scruth E
Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
[No Abstract] [Full Text] [Related]
13. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance.
Rabinowitz J; Davidson M; De Deyn PP; Katz I; Brodaty H; Cohen-Mansfield J
Am J Geriatr Psychiatry; 2005 Nov; 13(11):991-8. PubMed ID: 16286443
[TBL] [Abstract][Full Text] [Related]
14. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
15. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
Pollock BG; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Huber KA
Am J Geriatr Psychiatry; 2007 Nov; 15(11):942-52. PubMed ID: 17846102
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of risperidone for behavioral disorders in the elderly: a clinical observation.
Raheja RK; Bharwani I; Penetrante AE
J Geriatr Psychiatry Neurol; 1995 Jul; 8(3):159-61. PubMed ID: 7576039
[TBL] [Abstract][Full Text] [Related]
18. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update.
DeVane CL; Mintzer J
Psychopharmacol Bull; 2003; 37(4):116-32. PubMed ID: 15131522
[TBL] [Abstract][Full Text] [Related]
19. Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.
West AE; Weinstein SM; Celio CI; Henry D; Pavuluri MN
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):545-53. PubMed ID: 22136096
[TBL] [Abstract][Full Text] [Related]
20. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
